Literature DB >> 33090364

Spontaneous splenic rupture, mesenteric ischemia and spinal infarction after aortic repair for acute type A dissection in a patient with sickle cell trait.

Makoto Toyoda1, Tadashi Kitamura2, Kouki Nakashima3, Yoshikiyo Matsunaga3, Masaki Nie3, Kagami Miyaji2.   

Abstract

Sickle cell trait (SCT), a benign hematological condition affecting approximately 300 million individuals globally, is associated with an increased risk of vaso-occlusive disease. However, the risks related to surgery employing cardiopulmonary bypass in patients with SCT are not well established. Herein, we report the case of a 27-year-old African American man with SCT who underwent an emergency aortic repair for acute Stanford type A aortic dissection using hypothermic circulatory arrest. The patient developed a sickle cell crisis, which was followed by spontaneous splenic infarction and rupture, nonocclusive mesenteric ischemia, and spinal infarction.

Entities:  

Keywords:  Aortic dissection; Mesenteric ischemia; Sickle cell trait; Spinal infarction; Splenic rupture

Mesh:

Year:  2020        PMID: 33090364      PMCID: PMC7900333          DOI: 10.1007/s11748-020-01520-1

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  8 in total

Review 1.  Sickle-cell disease.

Authors:  Marie J Stuart; Ronald L Nagel
Journal:  Lancet       Date:  2004 Oct 9-15       Impact factor: 79.321

Review 2.  Sickle Cell Trait: A Benign State?

Authors:  Taiwo R Kotila
Journal:  Acta Haematol       Date:  2016-07-16       Impact factor: 2.195

Review 3.  Management of sickle cell disease in patients undergoing cardiac surgery.

Authors:  Todd C Crawford; Michael V Carter; Rina K Patel; Alejandro Suarez-Pierre; Sophie Z Lin; Jonathan Trent Magruder; Joshua C Grimm; Duke E Cameron; William A Baumgartner; Kaushik Mandal
Journal:  J Card Surg       Date:  2017-01-16       Impact factor: 1.620

4.  Open heart surgery in patients with sickle cell hemoglobinopathy.

Authors:  Sajjad M Yousafzai; Murat Ugurlucan; Omar A Al Radhwan; Amal L Al Otaibi; Charles C Canver
Journal:  Circulation       Date:  2009-12-21       Impact factor: 29.690

5.  Public health implications of sickle cell trait: a report of the CDC meeting.

Authors:  Althea M Grant; Christopher S Parker; Lanetta B Jordan; Mary M Hulihan; Melissa S Creary; Michele A Lloyd-Puryear; Jonathan C Goldsmith; Hani K Atrash
Journal:  Am J Prev Med       Date:  2011-12       Impact factor: 5.043

6.  Hypothermic cardiopulmonary bypass without exchange transfusion in sickle-cell patients: a matched-pair analysis.

Authors:  Frank Edwin; Ernest Aniteye; Mark Tettey; Martin Tamatey; Kow Entsua-Mensah; Ernest Ofosu-Appiah; Lawrence Sereboe; Baffoe Gyan; Innocent Adzamli; Kwabena Frimpong-Boateng
Journal:  Interact Cardiovasc Thorac Surg       Date:  2014-07-30

Review 7.  Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.

Authors:  Barbara P Yawn; George R Buchanan; Araba N Afenyi-Annan; Samir K Ballas; Kathryn L Hassell; Andra H James; Lanetta Jordan; Sophie M Lanzkron; Richard Lottenberg; William J Savage; Paula J Tanabe; Russell E Ware; M Hassan Murad; Jonathan C Goldsmith; Eduardo Ortiz; Robinson Fulwood; Ann Horton; Joylene John-Sowah
Journal:  JAMA       Date:  2014-09-10       Impact factor: 56.272

8.  Clinical Outcomes Associated With Sickle Cell Trait: A Systematic Review.

Authors:  Rakhi P Naik; Kim Smith-Whitley; Kathryn L Hassell; Nkeiruka I Umeh; Mariane de Montalembert; Puneet Sahota; Carlton Haywood; Jean Jenkins; Michele A Lloyd-Puryear; Clinton H Joiner; Vence L Bonham; Gregory J Kato
Journal:  Ann Intern Med       Date:  2018-10-30       Impact factor: 25.391

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.